Inventor · disambiguated record
William N. Haining
Also filed as: HAINING WILLIAM N · HAINING WILLIAM NICHOLAS
6 granted patents·6 pending applications·1 citations·filing 2004–2020
65Inventor score
Top patents by PatentIndex Score
12 records- 0165US10927410B2Compositions and methods for identification, assessment, prevention, and treatment of T-cell exhaustion using CD39 biomarkers and modulatorsDANA FARBER CANCER INST INC·Filed 2015·Granted Feb 23, 2021·1 cites·7 claims
- 0255US2005123596A1pH-triggered microparticlesFiled 2004·Application pending·0 cites
- 0354US12050219B2Modulating biomarkers such as SPP to increase tumor immunity and improve the efficacy of cancer immunotherapyDANA FARBER CANCER INST INC·Filed 2020·Granted Jul 30, 2024·0 cites·20 claims
- 0448US11740242B2Modulating biomarkers to increase tumor immunity and improve the efficacy of cancer immunotherapyDANA FARBER CANCER INST INC·Filed 2018·Granted Aug 29, 2023·0 cites·4 claims
- 0547US11873486B2Modulating dsRNA editing, sensing, and metabolism to increase tumor immunity and improve the efficacy of cancer immunotherapy and/or modulators of intratumoral interferonDANA FARBER CANCER INST INC·Filed 2018·Granted Jan 16, 2024·0 cites·18 claims
- 0645US2022017921A1Improved vector systems for cas protein and sgrna delivery, and uses thereforBROAD INST INC·Filed 2019·Application pending·0 cites
- 0743US2022081691A1Modulating ptpn2 to increase immune responses and perturbing gene expression in hematopoietic stem cell lineagesDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 0842US2020149042A1Modulating biomarkers to increase tumor immunity and improve the efficacy of cancer immunotherapyHAINING WILLIAM N·Filed 2018·Application pending·0 cites
- 0941US10653123B2Methods and compositions for perturbing gene expression in hematopoietic stem cell lineages in vivoDANA FARBER CANCER INST INC·Filed 2015·Granted May 19, 2020·0 cites·18 claims
- 1039US2021309965A1T-cell exhaustion state-specific gene expression regulators and uses thereofDANA FARBER CANCER INST INC·Filed 2017·Application pending·0 cites
- 1138US2020300859A1Modulating biomarkers to increase tumor immunity and improve the efficacy of cancer immunotherapyDANA FARBER CANCER INST INC·Filed 2018·Application pending·0 cites
- 1228US11179480B2In vivo methods for identifying cancer-associated immunotherapy targetsDANA FARBER CANCER INST INC·Filed 2015·Granted Nov 23, 2021·0 cites·33 claims
Join the waitlist — get patent alerts
Get an alert when William N. Haining files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →